The risk of death linked to Merck's anti-inflammatory drug Vioxx was minimized in trial studies the company made public, according to a study out Tuesday. The risk of death linked to Merck's anti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback